Skip to main content

Share Article

Urenco Isotopes launches Blaise Pascal installation to expand its critical supply

14 May 2025 Global News

This expansion comes at a crucial time as the global shortage of critical isotopes continues to impact various sectors.

Urenco Isotopes is proud to announce the successful commissioning of its newest isotope enrichment installation, Blaise Pascal, dedicated to the production of germanium, xenon, selenium, and silicon.

This expansion comes at a crucial time as the global shortage of critical isotopes continues to impact various sectors, including medicine, technology, and industry. The Blaise Pascal installation represents a significant step forward in addressing these shortages and enhancing Urenco’s capacity to deliver high-quality isotope products.

The installation strengthens Urenco’s position as a trusted provider of advanced isotope products, supporting a broad spectrum of applications including life-saving medical treatments, cutting-edge semiconductor technologies, and clean energy innovation.

It also enables Urenco to better serve its customers and partners across industries that rely on stable isotopes. With a track record of delivering high-quality isotopes and a growing role in enabling future-focused industries, Urenco Isotopes remains at the forefront of isotope innovation. 

Head of Isotopes, Linda Ashton, said: 

"The launch of the Blaise Pascal installation marks a significant milestone for Urenco Isotopes. 

"In a time when the global demand for critical isotopes is at an all-time high, we are proud to contribute to support the continued production and strengthen the supply chain, increasing supply security with our state-of-the-art facility.

"This development not only reinforces our commitment to innovation and excellence but also ensures that we continue to support vital industries and applications worldwide."

 

About Urenco Isotopes

Urenco Isotopes is a leading global provider of stable and medical isotopes, supporting applications across healthcare, industry, research, and energy. With a strong focus on quality, safety and innovation, Urenco enables essential progress in science and society.

www.urencoisotopes.com 
 

Share Article

Line

More global stories

2030 emissions target within reach as Urenco agrees to new power supplies

Global 07 May 2025

All four of our enrichment sites have now secured a low-carbon supply of electricity under scope 2.

Read more 2030 emissions target within reach as Urenco agrees to new power supplies

All four of our enrichment sites have now secured a low-carbon supply of electricity under scope 2.

Read more 2030 emissions target within reach as Urenco agrees to new power supplies

Urenco stands with world leaders on energy security

Global 01 May 2025

The Summit was an opportunity to cooperate on rising challenges to the world’s energy systems.

Read more Urenco stands with world leaders on energy security

The Summit was an opportunity to cooperate on rising challenges to the world’s energy systems.

Read more Urenco stands with world leaders on energy security

About Urenco

Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.

With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.

Back to
the goals